ASHRAF CURRIMBHOY: Open Payments
NPI 1336470376 · FORNEY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,470 in 142 payments from 17 companies in 2025. Trend: 2023 $1,679 · 2024 $2,307 · 2025 $2,470
Food & beverage: $2,460Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $421 |
| Galderma Laboratories, L.P. | 27 | $355 |
| UCB, Inc. | 16 | $335 |
| Organon LLC | 18 | $265 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 12 | $240 |
| Arcutis Biotherapeutics, Inc. | 17 | $228 |
| Janssen Biotech, Inc. | 8 | $156 |
| Lilly USA, LLC | 4 | $81 |
| Incyte Corporation | 3 | $72 |
| Regeneron Healthcare Solutions, Inc. | 3 | $71 |
Products named: Bimzelx, NEMLUVIO, Zoryve, SKYRIZI, ILUMYA, RINVOQ, TREMFYA, VTAMA.
Industry payments across TX — which companies pay providers there.
